Drug
Rviii Singlechain
Rviii Singlechain: highest development phase Phase 3, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| rVIII-SingleChain NCT02093897 | Phase 3 | Congenital Hemophilia A |
Latest
No recent events.
Follow Rviii Singlechain on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.